Talk:Viceroy Research

This article is rated Stub-class on Wikipedia's content assessment scale.
It is of interest to the following WikiProjects:

Companies Low‑importance

This article is within the scope of WikiProject Companies, a collaborative effort to improve the coverage of companies on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.CompaniesWikipedia:WikiProject CompaniesTemplate:WikiProject Companiescompany articles

Low This article has been rated as Low-importance on the project's importance scale.

WikiProject Companies To-do:

Here are some tasks awaiting attention:

Article requests : Wikipedia:Requested articles/Business and economics/Companies
Assess : Category:Unassessed company articles
Copyedit : Category:Company articles needing attention
Infobox : Category:Company articles needing infoboxes
Maintain : Portal:Companies
Stubs : Help expand stub articles located at Category:Company stubs
Other :
- Tag company articles with the {{portal|Companies}} template
- Tag company talk pages with the {{WikiProject Companies}} project banner
- Answer requests for comments

Adding ticker templates to list of reports?

Wouldn't it be a great idea if we used the ticker templates for the tickers in the list? That would also standardize the convention around them. Now it is~mostly Bloomberg ticker? Category:Ticker_symbol_templates --Orubblig (talk) 17:44, 27 August 2023 (UTC)[reply]

This is the account of Viceroy Research. This page appears to be maliciously edited with several inaccuracies. 1. Viceroy Research is engaged in litigation with Medical Properties Trust. 2. Adler Group did not sue Viceroy Research and nothing in the referenced article states this. The article only states that Caner filed a lawsuit against Perring and Viceroy. Viceroy never agreed to pay Adler any sum. 3. GNC holdings has never sued Viceroy Research. There is no reference for this information. 4. The UK Financial Conduct Authority has never fined Viceroy Research. There is no reference for this information. 5. The UK Financial Conduct Authority did not open “questions into Viceroy Research's relationship with Cayman Island hedge fund Oasis Management”. This was done by Home REIT, a company whose internal investigation found “undeclared potential conflicts of interest” and “lack of transparency”. There is no mention in the referenced article of the FCA. 6. The US SEC has never charged Viceroy Research with “making false and misleading statements in a research report about the company Sino Biopharmaceutical”. Viceroy has never published a report on Sino Biopharmaceutical. There is no reference for this information. 7. BaFin has never fined Viceroy Research regarding its work into Grenke. There is no reference for this information. 8. The fine imposed by the FSCA on Viceroy Research was set aside by the Financial Services Tribunal https://www.iol.co.za/business-report/companies/viceroys-r50m-capitec-fine-set-aside-by-tribunal-82454ab0-690e-4ac5-8fab-d9f9814d8520 — Preceding unsigned comment added by ViceroyResearch (talk • contribs) 13:50, 20 November 2023 (UTC)[reply]